Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
Asian Pacific Journal of Cancer Prevention : APJCP|May 30, 2014
Clinical efficacy of bevacizumab concomitant with pemetrexed in patients with advanced non-small cell lung cancerYu-Mei Zhang, Yong-Qiang Li, Zhi-Hui Liu, et al.
Frontiers in Oncology|October 24, 2022
Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinomaKang Chen, Cheng-Piao Luo, De-Xiang Ge, et al.
Viral Immunology|November 27, 2024
Ubiquitination of P53 Regulated by Ubiquitin-Specific Protease 14 Delays the Invasion of Hepatitis B Virus and the Development of HepatitisTao Bai, Rong-Yun Mai, Zhi-Hong Tang, et al.
Plos One|October 1, 2014
Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertensionJian-Hong Zhong, Hang Li, Nan Xiao, et al.
Annals of Surgical Oncology|January 6, 2011
Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virusNing-Fu Peng, Le-Qun Li, Xiao Qin, et al.
Experimental and Therapeutic Medicine|January 21, 2017
Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinomaYin-Nong Zhao, Yong-Quan Zhang, Jia-Zhou Ye, et al.
World Journal of Gastroenterology|November 8, 2016
Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survivalHao-Jie Yang, Jing-Hang Jiang, Yu-Ting Yang, et al.
Bioscience Reports|June 2, 2020
Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomyRong-Rui Huo, Xu Liu, Jing Cui, et al.
World Journal of Gastroenterology|April 8, 2016
Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal veinHai-Hong Ye, Jia-Zhou Ye, Zhi-Bo Xie, et al.
Frontiers in Oncology|January 28, 2021
Dose-Response Between Serum Prealbumin and All-Cause Mortality After Hepatectomy in Patients With Hepatocellular CarcinomaRong-Rui Huo, Hao-Tian Liu, Zhu-Jian Deng, et al.
Pageof 21